HomeCompareBWV vs NOBL

BWV vs NOBL: Dividend Comparison 2026

BWV yields 1109.88% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BWV wins by $47035737.27M in total portfolio value
10 years
BWV
BWV
● Live price
1109.88%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47035737.30M
Annual income
$39,954,235,177,691.26
Full BWV calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — BWV vs NOBL

📍 BWV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBWVNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BWV + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BWV pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BWV
Annual income on $10K today (after 15% tax)
$94,339.62/yr
After 10yr DRIP, annual income (after tax)
$33,961,099,901,037.57/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, BWV beats the other by $33,961,099,900,825.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BWV + NOBL for your $10,000?

BWV: 50%NOBL: 50%
100% NOBL50/50100% BWV
Portfolio after 10yr
$23517868.66M
Annual income
$19,977,117,588,970.52/yr
Blended yield
84.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BWV right now

BWV
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Price Target
$4.00
+2119.8% upside vs current
Range: $4.00 — $4.00
Altman Z
-9.6
Piotroski
4/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BWV buys
0
NOBL buys
0
No recent congressional trades found for BWV or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBWVNOBL
Forward yield1109.88%2.17%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$47035737.30M$22.9K
Annual income after 10y$39,954,235,177,691.26$249.78
Total dividends collected$46502201.88M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BWV vs NOBL ($10,000, DRIP)

YearBWV PortfolioBWV Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$121,688$110,987.79$10,917$217.08+$110.8KBWV
2$1,392,436$1,262,229.83$11,903$221.48+$1.38MBWV
3$14,988,323$13,498,416.50$12,962$225.68+$14.98MBWV
4$151,830,358$135,792,852.99$14,099$229.68+$151.82MBWV
5$1,448,037,323$1,285,578,839.42$15,319$233.49+$1448.02MBWV
6$13,008,119,121$11,458,719,185.11$16,628$237.10+$13008.10MBWV
7$110,121,340,317$96,202,652,857.66$18,033$240.53+$110121.32MBWV
8$878,962,312,032$761,132,477,893.38$19,539$243.78+$878962.29MBWV
9$6,618,226,279,560$5,677,736,605,685.80$21,154$246.86+$6618226.26MBWV
10$47,035,737,296,821$39,954,235,177,691.26$22,884$249.78+$47035737.27MBWV

BWV vs NOBL: Complete Analysis 2026

BWVStock

Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.

Full BWV Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this BWV vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BWV vs SCHDBWV vs JEPIBWV vs OBWV vs KOBWV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.